Impact BioMedical Inc. (IBO) KPIs and segments

IBONYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30

$3.06+0.38 (+14.18%)

Close on Oct 19, 2026Market cap $26.14MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Impact BioMedical's business

Coming soon

This tab will track the numbers specific to Impact BioMedical's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?